Fimiani C - Search Results

1

Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort.

Lazzaro A, Bianchini D, Gentilini Cacciola E, Mezzaroma I, Falciano M, Andreoni C, Fimiani C, Santinelli L, Maddaloni L, Bugani G, Ceccarelli G, Mastroianni CM, d'Ettorre G. Lazzaro A, et al. Among authors: fimiani c. Viruses. 2023 May 23;15(6):1222. doi: 10.3390/v15061222. Viruses. 2023. PMID: 37376522 Free PMC article.

2

T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.

Marziali M, De Santis W, Carello R, Leti W, Esposito A, Isgrò A, Fimiani C, Sirianni MC, Mezzaroma I, Aiuti F. Marziali M, et al. Among authors: fimiani c. AIDS. 2006 Oct 24;20(16):2033-41. doi: 10.1097/01.aids.0000247588.69438.fd. AIDS. 2006. PMID: 17053349

3

Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected individuals.

Turriziani O, Bucci M, Stano A, Scagnolari C, Bellomi F, Fimiani C, Mezzaroma I, D'Ettorre G, Brogi A, Vullo V, Antonelli G. Turriziani O, et al. Among authors: fimiani c. J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):518-24. doi: 10.1097/QAI.0b013e3180315515. J Acquir Immune Defic Syndr. 2007. PMID: 17224845

4

Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.

Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I. Isgrò A, et al. Among authors: fimiani c. Clin Infect Dis. 2008 Jun 15;46(12):1902-10. doi: 10.1086/588480. Clin Infect Dis. 2008. PMID: 18462177

5

Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.

Michelini Z, Baroncelli S, Fantauzzi A, Pasquale C, Galluzzo CM, Sanchez M, Gatto M, Amici R, Franco M, d'Ettorre G, Fimiani C, Mezzaroma I, Vullo V, Merli M, Palmisano L. Michelini Z, et al. Among authors: fimiani c. HIV Clin Trials. 2016 Mar;17(2):49-54. doi: 10.1080/15284336.2015.1125077. Epub 2016 Jan 7. HIV Clin Trials. 2016. PMID: 26739837 Clinical Trial.

6

Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.

Falasca F, Di Carlo D, De Vito C, Bon I, d'Ettorre G, Fantauzzi A, Mezzaroma I, Fimiani C, Re MC, Vullo V, Antonelli G, Turriziani O. Falasca F, et al. Among authors: fimiani c. BMC Infect Dis. 2017 Aug 22;17(1):581. doi: 10.1186/s12879-017-2676-2. BMC Infect Dis. 2017. PMID: 28830393 Free PMC article.

7

Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study.

Pavone P, Giustini N, Fimiani C, Paoletti F, Falciano M, Salotti A, Di Sora F, Al Moghazi S, Mezzaroma I, Vullo V, d'Ettorre G. Pavone P, et al. Among authors: fimiani c. Curr HIV Res. 2017 Nov 23;15(5):355-360. doi: 10.2174/1570162X15666170927124558. Curr HIV Res. 2017. PMID: 28969567

8

Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients.

Falasca F, De Vito C, Mazzuti L, di Carlo D, Celani L, Fimiani C, dʼEttorre G, Mezzaroma I, Antonelli G, Turriziani O. Falasca F, et al. Among authors: fimiani c. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):423-428. doi: 10.1097/QAI.0000000000001931. J Acquir Immune Defic Syndr. 2019. PMID: 30531307

9

Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience.

Mazzuti L, Melengu T, Falasca F, Calabretto M, Cella E, Ciccozzi M, Mezzaroma I, Iaiani G, Spaziante M, d'Ettorre G, Fimiani C, Vullo V, Antonelli G, Turriziani O. Mazzuti L, et al. Among authors: fimiani c. J Glob Antimicrob Resist. 2020 Mar;20:298-303. doi: 10.1016/j.jgar.2019.08.024. Epub 2019 Sep 10. J Glob Antimicrob Resist. 2020. PMID: 31518723 Free article.

10

Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort.

Santinelli L, Ceccarelli G, Borrazzo C, Celani L, Pavone P, Innocenti GP, Spagnolello O, Fimiani C, Ceci F, Di Sora F, Mezzaroma I, Mastroianni CM, d'Ettorre G. Santinelli L, et al. Among authors: fimiani c. Expert Rev Anti Infect Ther. 2020 May;18(5):485-492. doi: 10.1080/14787210.2020.1733415. Epub 2020 Feb 25. Expert Rev Anti Infect Ther. 2020. PMID: 32096433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page